33 / 140
155
22. Garimella PS, Hart PD, O’Hare A, et al.: Peripheral artery disease and
CKD: A focus on peripheral artery disease as a critical component of
CKD care. Am J Kidney Dis. 2012; 60:641-654.
23. Kurella Tamura M, Wadley V, Yaffe K, et al.: Kidney function and cognitive
impairment in US adults: The Reasons for Geographic and Racial
Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008; 52:227-
234.
24. Seliger SL, Gillen DL, Longstreth WT Jr, et al.: Elevated risk of stroke
among patients with end-stage renal disease. Kidney Int. 2003;
64:603-609.
25. Carrero JJ, Evans M, Szummer K, et al.: Warfarin, kidney dysfunction,
and outcomes following acute myocardial infarction in patients with
atrial fibrillation. JAMA. 2014; 311:919-928.
26. Park M, Hsu CY, Li Y, et al.: Associations between kidney function and
subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012;
23:1725-1734.
27. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, et al.: Fluid retention is
associated with cardiovascular mortality in patients undergoing long-
term hemodialysis. Circulation 2009; 119:671-679.
28. Alpert MA, Ravenscraft MD: Pericardial involvement in end-stage renal
disease. Am J Med Sci. 2003, 325:228-236.
29. Ureña P, Malergue MC, Goldfarb B, et al.: Evolutive aortic stenosis in
hemodialysis patients: Analysis of risk factors. Nephrologie 1999;
20:217-225.
30. Chan V, Chen L, Mesana L, et al.: Heart valve prosthesis selection in
patients with end-stage renal disease requiring dialysis: A systematic
review and meta-analysis. Heart 2011; 97:2033-2037.
31. Shastri S, Tangri N, Tighiouart H, et al.: Predictors of sudden cardiac
death: A competing risk approach in the hemodialysis study. Clin J Am
Soc Nephrol. 2012; 7:123-130.
32. Davis TR, Young BA, Eisenberg MS, et al.: Outcome of cardiac arrests
attended by emergency medical services staff at community outpatient
dialysis centers. Kidney Int. 2008; 73:933-939.
33. Charytan DM, Patrick AR, Liu J, et al.: Trends in the use and outcomes of
implantable cardioverter-defibrillators in patients undergoing dialysis
in the United States. Am J Kidney Dis. 2011; 58:409-417.
34. Kestenbaum B, Rudser KD, Shlipak MG, et al.: Kidney function,
electrocardiographic findings, and cardiovascular events among older
adults. Clin J Am Soc Nephrol. 2007; 2:501-508.
35. Bergeron S, Hillis GS, Haugen EN, et al.: Prognostic value of dobutamine
stress echocardiography in patients with chronic kidney disease. Am
Heart J. 2007; 153:385-391.
36. Wang LW, FahimMA, Hayen A, et al.: Cardiac testing for coronary artery
disease in potential kidney transplant recipients. Cochrane Database
Syst Rev. 2001; 12.
37. Kumar N, Dahri L, Brown W, et al.: Effect of elective coronary
angiography on glomerular filtration rate in patients with advanced
chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4:1907-1913.
38. Fujimoto N, Iseki K, Tokuyama K, et al.: Significance of coronary artery
calcification score (CACS) for the detection of coronary artery disease
(CAD) in chronic dialysis patients. Clin Chim Acta 2006; 367:98-102.
39. Breidthardt T, Burton JO, Odudu A, et al.: Troponin T for the detection of
dialysis-induced myocardial stunning in hemodialysis patients. Clin J
Am Soc Nephrol. 2012; 7:1285-1292.
[ENFERMEDAD CARDIOVASCULAR (ECV) EN LA ENFERMEDAD RENAL CRÓNICA (ERC) - Dr. Rodrigo Orozco B.]
40. Stack AG, Molony DA, Rives T, et al.: Association of physical activity
with mortality in the US dialysis population. Am J Kidney Dis. 2005;
45:690-701.
41. He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-
analysis of outcome trials. Lancet 2011; 378: 380–82.
42. Ninomiya T, Perkovic V, Turnbull F et al.: Blood Pressure Lowering
Treatment Trialists’ Collaboration. BMJ. 2013; 347:f5680.
43. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal
outcomes: a meta-analysis. J Am Soc Nephrol. 2006; 17(7):2006.
44. Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am
J Med Sci. 1998; 316:94–104.
45. Palmer SC, Di Micco L, Razavian M et al. Antiplatelet agents for chronic
kidney disease. Cochrane Database Syst Rev. 2013; 2: CD008834.
46. Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin use associates
with increased risk for stroke in hemodialysis patients with atrial
fibrillation. J Am Soc Nephrol 2009; 20:2223–33.
47. Fox CS, Muntner P, Chen AY, et al. Use of evidence-based therapies in
short-term outcomes on ST-segment elevation miocardial infarction
and non-ST-segment elevation myocardial infarction in patients with
chronic kidney disease: a report from the National Cardiovascular
Data Acute Coronary Treatment and Intervention Outcomes Network
Registry. Circulation 2010; 121:357–65.
48. Shroff GR, Solid CA, Herzog CA: Long-term survival and repeat coronary
revascularization in dialysis patients after surgical and percutaneous
coronary revascularization with drug-eluting and bare metal stents in
the United States. Circulation 2013; 127:1861-1869.
49. Chang TI, Shilane D, Kazi DS, et al.: Multivessel coronary artery bypass
grafting versus percutaneous coronary intervention in ESRD. J Am Soc
Nephrol. 2012; 23:2042-2049.